+987.9%
MRNA vs GEHC
+15.6%
+972.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GEHC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +6.4% | +6.7% | +7.5% |
| 7D | +20.6% | +13.2% | +7.5% | +8.6% |
| 30D | +27.1% | +30.6% | -3.5% | -0.3% |
| 3M | +353.4% | +22.2% | +331.2% | +291.6% |
| 6M | +446.3% | +40.8% | +405.4% | +333.9% |
| YTD | +776.2% | +4.8% | +771.3% | +717.3% |
| 1Y | +987.9% | +15.7% | +972.2% | +896.5% |
| All | +987.9% | +15.6% | +972.4% | +896.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GEHC.
Daily Out/Under-Performance
Portfolio return minus GEHC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GEHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GEHC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling